Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034199196> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2034199196 abstract "Axillary node status is one of the strongest prognostic factors in breast cancer patients. The presence of tumor in axillary nodes, and number of positive nodes, predicts risk of metastatic disease and long term survival. In the past, axillary dissection provided both accurate evaluation of nodal status and excellent local control. However, complications of axillary dissection, including lymphedema, pain, and impaired arm function, have led to keen interest in alternatives to axillary dissection for local control and assessment of prognosis. Sentinel node biopsy provides a low-morbidity alternative to axillary dissection for patients with clinically negative nodes. It was recognized that breast lymphatics converge in the axilla, delivering fluid, travelling tumor cells and dye particles to a small number of “sentinel” nodes. Sentinel node biopsy techniques take advantage of this lymphatic anatomy using dye injection intraoperatively to permit identification and removal of only the most important axillary nodes - those most likely to contain metastases. A negative sentinel node provides accurate staging and reliably predicts a low axillary recurrence rate, eliminating the need for dissection. Sentinel node mapping also allows study of the relationship between the size of a nodal metastasis and impact on prognosis. Sentinel node mapping techniques, morbidity, and data on the reliability of sentinel node biopsy will be reviewed. 40–50% of patients with a positive sentinel node will have additional positive axillary nodes, indicating a need for additional axillary treatment for local control. Completion axillary dissection was initially used for local control and prognostic assessment in patients with a positive sentinel node. Recently, the ACOSOG Z0011 trial showed that patients with 1 or 2 positive sentinel nodes who receive standard whole breast irradiation without further axillary surgery have equivalent local control as patients having completion axillary dissection. Axillary recurrence rates in the Z0011 trial were Management of the axilla will evolve further as options for assessment of tumor and host factors increase. Gene expression profiling may prove more important than primary tumor size and node status for predicting prognosis and guiding therapy - an approach already used in estrogen receptor positive tumors. Future options for incorporating axillary node status with tumor and host factors in breast cancer management will be considered. Citation Information: Cancer Res 2011;71(24 Suppl):Abstract nr PL3-1." @default.
- W2034199196 created "2016-06-24" @default.
- W2034199196 creator A5044369303 @default.
- W2034199196 date "2011-12-15" @default.
- W2034199196 modified "2023-09-27" @default.
- W2034199196 title "PL3-1: Advances in Axillary Surgery: Sentinel Nodes and beyond." @default.
- W2034199196 doi "https://doi.org/10.1158/0008-5472.sabcs11-pl3-1" @default.
- W2034199196 hasPublicationYear "2011" @default.
- W2034199196 type Work @default.
- W2034199196 sameAs 2034199196 @default.
- W2034199196 citedByCount "0" @default.
- W2034199196 crossrefType "proceedings-article" @default.
- W2034199196 hasAuthorship W2034199196A5044369303 @default.
- W2034199196 hasConcept C121608353 @default.
- W2034199196 hasConcept C126322002 @default.
- W2034199196 hasConcept C126838900 @default.
- W2034199196 hasConcept C141071460 @default.
- W2034199196 hasConcept C179671157 @default.
- W2034199196 hasConcept C2775934546 @default.
- W2034199196 hasConcept C2776608951 @default.
- W2034199196 hasConcept C2780212769 @default.
- W2034199196 hasConcept C2781392513 @default.
- W2034199196 hasConcept C2908949552 @default.
- W2034199196 hasConcept C2909835446 @default.
- W2034199196 hasConcept C530470458 @default.
- W2034199196 hasConcept C71924100 @default.
- W2034199196 hasConceptScore W2034199196C121608353 @default.
- W2034199196 hasConceptScore W2034199196C126322002 @default.
- W2034199196 hasConceptScore W2034199196C126838900 @default.
- W2034199196 hasConceptScore W2034199196C141071460 @default.
- W2034199196 hasConceptScore W2034199196C179671157 @default.
- W2034199196 hasConceptScore W2034199196C2775934546 @default.
- W2034199196 hasConceptScore W2034199196C2776608951 @default.
- W2034199196 hasConceptScore W2034199196C2780212769 @default.
- W2034199196 hasConceptScore W2034199196C2781392513 @default.
- W2034199196 hasConceptScore W2034199196C2908949552 @default.
- W2034199196 hasConceptScore W2034199196C2909835446 @default.
- W2034199196 hasConceptScore W2034199196C530470458 @default.
- W2034199196 hasConceptScore W2034199196C71924100 @default.
- W2034199196 hasLocation W20341991961 @default.
- W2034199196 hasOpenAccess W2034199196 @default.
- W2034199196 hasPrimaryLocation W20341991961 @default.
- W2034199196 hasRelatedWork W1518325034 @default.
- W2034199196 hasRelatedWork W1523639086 @default.
- W2034199196 hasRelatedWork W1821378923 @default.
- W2034199196 hasRelatedWork W1984054652 @default.
- W2034199196 hasRelatedWork W2008912941 @default.
- W2034199196 hasRelatedWork W2023720877 @default.
- W2034199196 hasRelatedWork W2030161068 @default.
- W2034199196 hasRelatedWork W2034997273 @default.
- W2034199196 hasRelatedWork W2085787192 @default.
- W2034199196 hasRelatedWork W2088373772 @default.
- W2034199196 hasRelatedWork W2239197114 @default.
- W2034199196 hasRelatedWork W2409903928 @default.
- W2034199196 hasRelatedWork W2512992346 @default.
- W2034199196 hasRelatedWork W262929021 @default.
- W2034199196 hasRelatedWork W2907926029 @default.
- W2034199196 hasRelatedWork W3138324612 @default.
- W2034199196 hasRelatedWork W315593853 @default.
- W2034199196 hasRelatedWork W3163452585 @default.
- W2034199196 hasRelatedWork W45805308 @default.
- W2034199196 hasRelatedWork W77671952 @default.
- W2034199196 isParatext "false" @default.
- W2034199196 isRetracted "false" @default.
- W2034199196 magId "2034199196" @default.
- W2034199196 workType "article" @default.